Management of immune-related adverse events: A single-center retrospective analysis in a real-world scenario.

被引：0
|
作者：
Iacono, Donatella
Vitale, Maria Grazia
Cortiula, Francesco
Macerelli, Marianna
Cinausero, Marika
Minisini, Alessandro Marco
Valent, Francesca
Tullio, Annarita
Palmero, Lorenza
Targato, Giada
Zara, Diego
Fasola, Gianpiero
机构：
[1] Univ Hosp Udine, Dept Oncol, Udine, Italy
[2] Univ Udine, Dept Med DAME, Udine, Italy
[3] Azienda Sanit Univ Integrata Udine, Dipartimento Oncol, Udine, Italy
[4] Univ Hosp Udine, Inst Hyg & Clin Epidemiol, Udine, Italy
[5] Univ Udine, Udine, Italy
[6] Univ Hosp Udine Santa Maria della Misericordia, Dept Oncol, Udine, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15163
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Pharmacist's role in immune-related adverse events management: real-world incidence and risk evaluation from immunotherapy
    Meanwatthana, J.
    Chantarasap, P.
    Chuatrisorn, I
    Wiriya, T.
    Jitawatanarat, P.
    INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2022, 30 (04) : 377 - 382
  • [22] Immune-related adverse events: Spectrum and clinical features in the real world
    Vieira, I. M.
    Pinelas, S.
    Gaspar, C.
    Dinis, J.
    Oliveira, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S1434 - S1434
  • [23] Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experience
    Bhatlapenumarthi, Vineel
    Patwari, Anannya
    Harb, Antoine J.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (09) : 2789 - 2800
  • [24] Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experience
    Vineel Bhatlapenumarthi
    Anannya Patwari
    Antoine J. Harb
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2789 - 2800
  • [25] IMMUNE-RELATED ADVERSE EVENTS FROM IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA: A REAL-WORLD EXPERIENCE
    Gampa, Anuhya
    Peeraphatdit, Thoetchai
    Charlton, Michael R.
    Pillai, Anjana A.
    HEPATOLOGY, 2020, 72 : 694A - 695A
  • [26] Real-world incidence of immune checkpoint inhibitor-related hepatitis: A single-center retrospective cohort study
    Peterson, A.
    Abasszade, J.
    Bell, S.
    Ratnam, D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 101 - 102
  • [27] Real-world incidences and risk factors of immune-related adverse events in patients treated with immune checkpoint inhibitors: A nationwide retrospective cohort study
    Kim, Yong Joon
    Lee, Myeongjee
    Kim, Eun Hwa
    Lee, Seulkee
    Park, Sejung
    Shin, Sang Joon
    Jung, Inkyung
    Lee, Choong-kun
    CANCER LETTERS, 2024, 596
  • [28] Serum markers as predictors of immune checkpoint inhibitors (ICI) related adverse events in a real-world scenario
    Iacono, D.
    Vitale, M. G.
    Cortiula, F.
    Cinausero, M.
    Tullio, A.
    Valent, F.
    Macerelli, M.
    Follador, A.
    Vogrig, A.
    Minisini, A. M.
    Puglisi, F.
    Fasola, G.
    ANNALS OF ONCOLOGY, 2018, 29
  • [29] Biologic efficacy in the treatment of cutaneous immune-related adverse events: A single center retrospective cohort study
    Ebriani, J.
    Westmeijer, M.
    Holt, A.
    Brumbaugh, B.
    Ma, K.
    Chen, S. T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S161 - S161
  • [30] Comment on Ophthalmic Immune-Related Adverse Events and Association With Survival: Results From a Real-World Database
    Lum, Flora
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2025, 270 : 277 - 277
12345